English | Español

Biospace
Patient Daily | Dec 21, 2025

Sanofi reports phase III failure and new FDA delay for MS drug
Patient Daily | Dec 20, 2025

Sobi acquires Arthrosi Therapeutics for $1.5 billion to expand into gout treatment
Patient Daily | Dec 19, 2025

Pfizer CEO criticizes HHS vaccine stance amid declining revenues
Patient Daily | Dec 19, 2025

Kyverna’s CAR T therapy shows strong results for stiff person syndrome
Patient Daily | Dec 19, 2025

Johnson & Johnson receives FDA priority voucher for multiple myeloma drug combination
Patient Daily | Dec 19, 2025

FDA approves first-line use of Enhertu for metastatic HER2-positive breast cancer
Patient Daily | Dec 19, 2025

Ambros raises $125M to bring Italian non-opioid pain drug to U.S. market
Patient Daily | Dec 19, 2025

Sanofi partners with South Korea's ADEL in $1B+ Alzheimer's drug development deal

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
+ Regulatory
Patient Daily | Mar 12, 2026

Texas Medical Association announces concerns over pharmacy benefit manager consolidation
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech